Navigation Links
Dynatronics Announces First Quarter Results
Date:11/14/2011

SALT LAKE CITY, Nov. 14, 2011 /PRNewswire/ -- Dynatronics Corporation (NASDAQ: DYNT) today announced results for its fiscal first quarter ended September 30, 2011.

Sales for the quarter ended September 30, 2011, increased one percent to $7,996,802, compared to $7,919,288 for the quarter ended September 30, 2010. Net loss for the quarter ended September 30, 2011, was $68,259 ($.01 per common share), compared to net income of $17,012 ($.00 per common share) for the same quarter in the prior fiscal year.

"Significant investment in R&D, combined with higher selling expenses associated with developing the Group Purchasing Organization (GPO) business, diminished our bottom-line results for the quarter," stated Kelvyn H. Cullimore Jr., chairman and president of Dynatronics. "Investing in the future through development of new products and cultivation of new sales opportunities like the GPOs can have a short-term negative impact on profitability, as it has this quarter, but is essential to the long-term financial health of the company."

"We expect to introduce new products in the spring of 2012 at which point R&D expenditures are expected to return to more traditional levels.  In addition, we expect to see greater progress with GPO's and national accounts in the coming quarters that will help justify the investment currently being made to cultivate that business," continued Cullimore.

In 2011, Dynatronics announced the signing of contracts with four GPOs: Premier, Inc., Amerinet, Inc., FirstChoice Cooperative and Champs Group Purchasing. These contracts became effective in March and June 2011.

"Developing business through these GPO contracts and seeking additional contracts with other GPOs and national accounts will continue to be a major focus for us for the next several years," stated Larry K. Beardall, executive vice president of sales and marketing. "Our sales directors are busy training our sales representatives on converting the new GPO clinics and hospitals to our brand. In addition, we are working with a dozen additional GPO groups and national accounts to sign preferred vendor contracts," added Beardall.

"With the new products under development and the potential of increased sales to new GPO clinics and national accounts, we continue to be optimistic about the future," Cullimore concluded.

Dynatronics has scheduled a conference call for investors on Monday, November 14, 2011, at 1:30 p.m. ET. Those wishing to participate should call (800) 926-5230 and use access code 5687000.

Following is a summary of the financial results as of September 30, 2011 and 2010, and for the three-month periods then ended:   Summary Selected Financial DataStatement of Income HighlightsThree Months EndedSeptember 30,20112010Net sales

$7,996,802

$7,919,288Cost of sales

4,994,704

4,967,455   Gross profit

3,002,098

2,951,833SG&A expenses

2,694,867

2,500,517R&D expenses

356,347

349,796Other expenses, net

56,812

71,783   Net income (loss) before income taxes

(105,928)

29,737Income tax benefit (provision)

37,669

(12,725)   Net income (loss)

$
(68,259)

$
7,012Diluted income (loss) per common share

$
(0.01)

$
.00
Balance Sheet HighlightsSeptember 30,June 30,20112011Cash

$
340,962

$
384,904Accounts receivable

3,862,602

3,672,128Inventories

5,789,189

5,647,815Total current assets

10,758,879

10,432,811Total assets

15,141,152

14,819,181Accounts payable

2,150,552

2,127,163Accrued expenses

358,706

379,336Line of credit

3,191,971

2,583,937Total current liabilities

6,653,876

5,880,080Total liabilities

8,879,399

8,204,022Total liabilities and equity

15,141,152

14,819,181Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.

This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements such as the statement regarding expectations for future new product line introductions and growth from GPO contracts. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost-effective rates, and the risk factors listed from time to time in the company's SEC reports including, but not limited to, the report on Form 10-K for the year ended June 30, 2011.


'/>"/>
SOURCE Dynatronics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics to Release Fiscal First Quarter Results Monday, November 14, 2011; Conference Call set for 1:30 p.m. ET
2. Dynatronics Announces Fourth Quarter and Year-end Results
3. Dynatronics to Release Fiscal Fourth Quarter and Year-end Results Wednesday, September 28, 2011; Conference Call Set for 1:00 p.m. ET
4. Dynatronics Appoints Bryan D. Alsop Vice President of Information Technology
5. Dynatronics Signs Agreement With CHAMPS Group Purchasing
6. Dynatronics Third Quarter Profits Increase 22%
7. Dynatronics to Release Fiscal Third Quarter Results Monday, May 16, 2011; Conference Call Set for 1:00 p.m. ET
8. Dynatronics Regains Compliance With NASDAQ
9. Dynatronics Selected for Inclusion in RB Milestone Portfolio
10. Dynatronics Signs Third GPO Contract in Two Months
11. Dynatronics Announces $1 Million Stock Buyback Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 8, 2016   HighPoint Solutions today ... (NRG),s pharmacovigilance technology services division.  NRG is a ... an Oracle Argus Specialized partner, providing drug safety ... companies. --> --> ... sciences capabilities and provides a global scale and ...
(Date:2/8/2016)... BOSTON , Feb. 8, 2016   Intarcia ... John Yee , MD, MPH, into the newly created ... Safety and Operations. Dr. Yee has two decades of ... companies, and at a major academic medical center. Most ... Affairs, US Diabetes, and VP, US Head Medical Officer ...
(Date:2/8/2016)... Calif. , Feb. 8, 2016 Lonza, a ... Sciences Inc., a biopharmaceutical company designing and developing novel ... agreements for the clinical supply of Kodiak,s therapeutic candidates. ... sites, including Slough (UK), Visp (CH) and Nansha (CN). ... Retinal diseases, such as age-related macular degeneration (AMD), cause ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... 09, 2016 , ... Sir Grout, the leading hard surface ... announce that many of their franchises have received the Super Service Award from ... franchises received customer recognition through positive reviews and testimonials, as well as evaluations ...
(Date:2/8/2016)... ... February 08, 2016 , ... CURE Media Group , the nation’s leading ... Multiple Myeloma Heroes Awards event , which will annually honor individuals making heroic contributions ... MM. The MM Heroes Awards nomination process is officially open through February ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... LA, celebrates the beginning of a new charity campaign. As part of their ... Special Advocates (CASA). In the belief that children deserve a voice, and in ...
(Date:2/8/2016)... ... February 08, 2016 , ... If you are feeling that your clothes ... not alone. According to the Center for Disease Control and Prevention (CDC), 34.9% of ... and certain types of cancer, some of the leading causes of preventable death. ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local insurance ... greater Venice, FL area, has initiated a fundraiser for a two year old ... four days after Christmas. To support this beautiful child who is facing life’s ...
Breaking Medicine News(10 mins):